HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Spencer J. Melby Tracey J. Guthrie Michael K. Pasque Marc R. Moon Ralph J. Damiano, Jr Nader Moazami Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zierer, A. Articles by Moazami, N. Search for Related Content PubMed PubMed Citation Articles by Zierer, A. Articles by Moazami, N. Related Collections Mechanical Circulatory Assistance Related Article

Ann Thorac Surg 2007;84:515-520
© 2007 The Society of Thoracic Surgeons

---

Original Articles: Cardiovascular

Late-Onset Driveline Infections: The Achilles’ Heel of Prolonged Left Ventricular Assist Device Support

^a Division of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, St. Louis, Missouri
^b Division of Cardiology, Washington University School of Medicine, Barnes-Jewish Hospital, St. Louis, Missouri

Accepted for publication March 27, 2007.

^_* Address correspondence to Dr Moazami, Division of Cardiothoracic Surgery, Washington University School of Medicine, 660 S Euclid Ave, Campus Box 8234, St. Louis, MO 62236 (Email: moazamin{at}wustl.edu).

Background: A successful left ventricular assist device (LVAD) long-term support in an outpatient setting demands that device-related complications are reduced to a minimum. We hypothesized that late onset driveline infections have serious implications on the anticipated application of LVAD as permanent therapy.

Methods: Between 1996 and 2005, 73 patients were implanted with the Novacor (World Heart Corp, Ottawa, Ontario, Canada; n = 35) or the HeartMate (Thoratec Corp, Pleasanton, CA; n = 38) as either bridge to transplantation (n = 44) or destination therapy (n = 29). Our analysis focused on patients with late-onset infection (30 days) of the driveline exit site with prior clinical healing of all incisions.

Results: Late driveline infections developed in 17 patients (23%) at a median of 158 days (intraquartile range [IQR]: 68 to 213 days) after implantation. The median duration of support in this subgroup was 400 days (IQR, 283 to 849 days). Despite an aggressive treatment algorithm, repeat surgical revision was needed in 12 patients, up to six times in 2 individuals. In 6 patients, the infection progressed to pump pocket infections that led to urgent heart transplantation (n = 4) or explantation (n = 2). The individual risk that a driveline infection would develop dramatically increased with the duration of support, reaching 94% at 1 year. Multivariate analysis identified duration of support (p < 0.001) and documented trauma at the driveline exit site (p < 0.001) as independent predictors of infection. Number and duration of readmissions to the hospital significantly increased (p < 0.001), and long-term follow-up for survival (4.4 ± 2.2 years, 100% complete) showed a trend towards impaired outcome after driveline infection (5-year survival: 41% versus 70%, p = 0.10).

Conclusions: Long-term LVAD support in the current series was jeopardized by late-onset driveline infections, which occurred in all patients with support duration longer than 1 year. Once driveline infections developed, they were difficult to control and significantly increased morbidity.

Related Article

Invited commentary

Paul Hendry
Ann. Thorac. Surg. 2007 84: 520-521. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				P. Hendry Invited commentary Ann. Thorac. Surg., August 1, 2007; 84(2): 520 - 521. [Full Text] [PDF]